Keywords: syntex, naprosyn, s/r, pharmaceuticals, launched, new, sustained-release
SYNTEX' NAPROSYN S/R
Article | 05 April 1993
- Syntex Pharmaceuticals has launched a new sustained-release formulation of its non-steroidal anti-inflammatory naproxen, called Naprosyn S/R, in the UK.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
